A Phase II Study of Submandibular Salivary Gland Transfer to the Submental Space Prior to Start of Radiation Treatment for Prevention of Radiation-induced Xerostomia in Head and Neck Cancer Patients: Initial Report of RTOG-0244

被引:0
|
作者
Jha, N. [1 ]
Harris, J. [2 ]
Seikaly, H. [3 ]
Jacobs, J. [4 ]
McEwan, A. [1 ]
Robbins, K. T. [5 ]
Grecula, J. [6 ]
Sharma, A. [7 ]
Ang, K. K. [8 ]
机构
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[2] Radiat Therapy Oncol Grp, Philadelphia, PA USA
[3] Univ Alberta, Edmonton, AB, Canada
[4] Wayne State Univ, Sch Med, Detroit, MI USA
[5] St Johns Hosp, Inst Canc, Springfield, IL USA
[6] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1016/j.ijrobp.2010.07.219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S80 / S81
页数:2
相关论文
共 47 条
  • [41] Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia
    Blitzer, Grace C.
    Paz, Cristina
    Glassey, Annemarie
    Ganz, Olga R.
    Giri, Jayeeta
    Pennati, Andrea
    Meyers, Ross O.
    Bates, Amber M.
    Nickel, Kwangok P.
    Weiss, Marissa
    Morris, Zachary S.
    Mattison, Ryan J.
    Mcdowell, Kimberly A.
    Croxford, Emma
    Chappell, Richard J.
    Glazer, Tiffany A.
    Rogus-Pulia, Nicole M.
    Galipeau, Jacques
    Kimple, Randall J.
    RADIOTHERAPY AND ONCOLOGY, 2024, 192
  • [42] A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of AqualiefTM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia
    Iacovelli, Nicola Alessandro
    Ingargiola, Rossana
    Facchinetti, Nadia
    Franceschini, Marzia
    Romanello, Domenico Attilio
    Bossi, Paolo
    Bergamini, Cristiana
    Alfieri, Salvatore
    Cavalieri, Stefano
    Baron, Giovanna
    Aldini, Giancarlo
    Locati, Laura
    Orlandi, Ester
    CANCERS, 2021, 13 (14)
  • [43] Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer
    Blitzer, Grace C.
    Rogus-Pulia, Nicole M.
    Mattison, Ryan J.
    Varghese, Tomy
    Ganz, Olga
    Chappell, Richard
    Galipeau, Jacques
    McDowell, Kimberly A.
    Meyers, Ross O.
    Glazer, Tiffany A.
    Kimple, Randall J.
    CYTOTHERAPY, 2022, 24 (05) : 534 - 543
  • [44] A phase III, randomized, sham-controlled trial of acupuncture for treatment of radiation-induced xerostomia (RIX) in patients with head and neck cancer: Wake Forest NCI Community Oncology Research Program Research Base (WF NCORP RB) trial WF-97115.
    Cohen, Lorenzo
    Danhauer, Suzanne
    Rosenthal, David Ira
    Chambers, Mark Steven
    Garcia, M. Kay
    Cusimano, Andrew
    Brown, Mark
    Dressler, Emily Van Meter
    Ochoa, Jewel
    Yang, Peiying
    Chiang, Joseph S.
    Gordon, Ora
    Crutcher, Rhonda
    Kim, Jung K.
    Russin, Michael P.
    Lukenbill, Joshua
    Porosnicu, Mercedes
    Yost, Kathleen J.
    Weaver, Kathryn E.
    Lesser, Glenn Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: A double-blind placebo-controlled prospective phase III study by radiation therapy oncology group 9901
    Ryu, Janice K.
    Swann, Suzanne
    LeVeque, Francis
    Scarantino, Charles W.
    Johnson, Darlene
    Chen, Allan
    Fortin, Andre
    Pollock, JonDavid
    Kim, Harold
    Ang, Kian K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (03): : 643 - 650
  • [46] Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment
    Lozano, A.
    Marruecos, J.
    Rubio, J.
    Farre, N.
    Gomez-Millan, J.
    Morera, R.
    Planas, I.
    Lanzuela, M.
    Vazquez-Masedo, M. G.
    Cascallar, L.
    Giralt, J.
    Escames, G.
    Valenti, V.
    Grima, P.
    Bosser, R.
    Tarrago, C.
    Mesia, R.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (09): : 1801 - 1810
  • [47] Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment
    A. Lozano
    J. Marruecos
    J. Rubió
    N. Farré
    J. Gómez-Millán
    R. Morera
    I. Planas
    M. Lanzuela
    M. G. Vázquez-Masedo
    L. Cascallar
    J. Giralt
    G. Escames
    V. Valentí
    P. Grima
    R. Bosser
    C. Tarragó
    R. Mesía
    Clinical and Translational Oncology, 2021, 23 : 1801 - 1810